Changbo Qu

508 total citations
16 papers, 357 citations indexed

About

Changbo Qu is a scholar working on Hepatology, Infectious Diseases and Immunology. According to data from OpenAlex, Changbo Qu has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 6 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Changbo Qu's work include Hepatitis Viruses Studies and Epidemiology (8 papers), Viral gastroenteritis research and epidemiology (5 papers) and Hepatitis C virus research (4 papers). Changbo Qu is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (8 papers), Viral gastroenteritis research and epidemiology (5 papers) and Hepatitis C virus research (4 papers). Changbo Qu collaborates with scholars based in Netherlands, China and Indonesia. Changbo Qu's co-authors include Qiuwei Pan, Maikel P. Peppelenbosch, Wenshi Wang, Shaoshi Zhang, Yuebang Yin, Lei Xu, Yang Li, Gwenny M. Fuhler, Yijin Wang and Yihang Pan and has published in prestigious journals such as Hepatology, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Changbo Qu

16 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changbo Qu Netherlands 12 127 118 102 81 46 16 357
Hanju Huang China 10 79 0.6× 79 0.7× 50 0.5× 100 1.2× 32 0.7× 24 294
Linbing Qu China 12 127 1.0× 28 0.2× 56 0.5× 92 1.1× 29 0.6× 22 325
Déborah Heydet Australia 8 102 0.8× 71 0.6× 50 0.5× 243 3.0× 21 0.5× 8 461
Gowri Kalugotla United States 7 148 1.2× 78 0.7× 72 0.7× 187 2.3× 29 0.6× 8 436
Nungki Anggorowati Indonesia 12 45 0.4× 102 0.9× 52 0.5× 111 1.4× 19 0.4× 36 298
Jingting Qiao China 5 227 1.8× 29 0.2× 73 0.7× 85 1.0× 35 0.8× 5 389
Dong-Yeop Chang South Korea 10 69 0.5× 83 0.7× 58 0.6× 98 1.2× 10 0.2× 10 437
O. V. Morozova Russia 9 133 1.0× 105 0.9× 129 1.3× 40 0.5× 42 0.9× 27 346

Countries citing papers authored by Changbo Qu

Since Specialization
Citations

This map shows the geographic impact of Changbo Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changbo Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changbo Qu more than expected).

Fields of papers citing papers by Changbo Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changbo Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changbo Qu. The network helps show where Changbo Qu may publish in the future.

Co-authorship network of co-authors of Changbo Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Changbo Qu. A scholar is included among the top collaborators of Changbo Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changbo Qu. Changbo Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lu, Yong-Ping, Bin Xia, Xiaohua Wang, et al.. (2025). Healthy dietary patterns and the incidence of chronic kidney disease: results from a prospective cohort study. BMC Public Health. 25(1). 511–511. 2 indexed citations
3.
Qu, Changbo, Jaap Keijer, Merel J.W. Adjobo-Hermans, et al.. (2021). The ketogenic diet as a therapeutic intervention strategy in mitochondrial disease. The International Journal of Biochemistry & Cell Biology. 138. 106050–106050. 27 indexed citations
4.
Qu, Changbo, Gwenny M. Fuhler, & Yihang Pan. (2021). Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?. International Journal of Molecular Sciences. 22(11). 5672–5672. 18 indexed citations
5.
Li, Yunlong, Changbo Qu, Bart Spee, et al.. (2020). Hepatitis E virus seroprevalence in pets in the Netherlands and the permissiveness of canine liver cells to the infection. Irish Veterinary Journal. 73(1). 6–6. 19 indexed citations
6.
Li, Yang, Peifa Yu, Changbo Qu, et al.. (2020). MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade. Antiviral Research. 176. 104743–104743. 17 indexed citations
7.
Li, Meng, Ling Wang, Yijin Wang, et al.. (2020). Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth. Cells. 9(1). 121–121. 81 indexed citations
8.
Qu, Changbo, Yang Li, Yunlong Li, et al.. (2019). FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis. Antiviral Research. 170. 104588–104588. 15 indexed citations
9.
Qu, Changbo, Shaoshi Zhang, Yang Li, et al.. (2019). Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections. Reviews in Medical Virology. 29(5). e2075–e2075. 17 indexed citations
10.
Li, Yang, Changbo Qu, Peifa Yu, et al.. (2019). The Interplay between Host Innate Immunity and Hepatitis E Virus. Viruses. 11(6). 541–541. 17 indexed citations
11.
Yin, Yuebang, Sunrui Chen, Mohamad S. Hakim, et al.. (2018). 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling. Antiviral Research. 156. 92–101. 41 indexed citations
12.
Qu, Changbo, Yijin Wang, Wenshi Wang, et al.. (2018). Conservation and variation of the hepatitis E virus ORF2 capsid protein. Gene. 675. 157–164. 8 indexed citations
13.
Qu, Changbo, et al.. (2018). The RNA genome of hepatitis E virus robustly triggers antiviral interferon response. Journal of Hepatology. 68. S794–S794. 1 indexed citations
14.
Qu, Changbo, Shaoshi Zhang, Wenshi Wang, et al.. (2018). Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target. The FASEB Journal. 33(1). 1008–1019. 21 indexed citations
15.
Qu, Changbo, Lei Xu, Yuebang Yin, et al.. (2017). Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin. Archives of Virology. 162(10). 2989–2996. 20 indexed citations
16.
Wang, Wenshi, Yijin Wang, Changbo Qu, et al.. (2017). The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response. Hepatology. 67(6). 2096–2112. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026